Advisornet Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $978 | Hold |
3
| – | – | ﹤0.01% | 1921 |
|
|
2025
Q1 | $810 | Hold |
3
| – | – | ﹤0.01% | 1886 |
|
|
2024
Q4 | $706 | Sell |
3
-8
| -73% | -$1.88K | ﹤0.01% | 1701 |
|
|
2024
Q3 | $3.03K | Buy |
11
+1
| +10% | +$275 | ﹤0.01% | 1671 |
|
|
2024
Q2 | $2.43K | Sell |
10
-13
| -57% | -$3.16K | ﹤0.01% | 1581 |
|
|
2024
Q1 | $3.44K | Buy |
23
+15
| +188% | +$2.24K | ﹤0.01% | 1510 |
|
|
2023
Q4 | $1.53K | Sell |
8
-1
| -11% | -$191 | ﹤0.01% | 1786 |
|
|
2023
Q3 | $1.59K | Sell |
9
-15
| -63% | -$2.66K | ﹤0.01% | 1698 |
|
|
2023
Q2 | $4.56K | Sell |
24
-10
| -29% | -$1.9K | ﹤0.01% | 1528 |
|
|
2023
Q1 | $6.81K | Buy |
34
+27
| +386% | +$5.41K | ﹤0.01% | 1403 |
|
|
2022
Q4 | $1.66K | Buy |
7
+5
| +250% | +$1.19K | ﹤0.01% | 1711 |
|
|
2022
Q3 | $0 | Buy |
+2
| New | – | ﹤0.01% | 1832 |
|